Research shows a simple blood test may determine if you have lung cancer

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Indi (Integrated Diagnostics) scientists have found that people with lung cancer have high levels of a certain proteins in their blood, that can distinguish between benign lung nodules and early-stage lung cancer.

Researchers found that a protein called isocitrate dehydrogenase is present at high levels in lung cancers and can be a marker for the disease.

“These studies suggest that Indi’s technology is capable of detecting the molecular signature of lung cancer by measuring the presence of multiple proteins in a patient’s blood,” said Paul Kearney, Ph.D., president and chief science officer

“We are very pleased that the data suggest we have achieved a 90 percent probability with this diagnostic classifier.”

For more information about the diagnostics of Pulmonary Nodules with a non-invasive blood test visit, Integrated Diagnostics

Latest News

More News

National News

More National

Washington D.C.

More Washington DC

Your Local Election HQ

More Your Local Election HQ
graphic of the Red Cross

Latest News

More News


KFOR Podcasts

More Podcasts

Follow @KFOR on Twitter